Cathy Eng

Trials

Studies that name Cathy Eng as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 17:44 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT04444921 · EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

  National Cancer Institute (NCI) · active not recruiting · Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Metastatic Anal Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT02560298 · Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer

  ECOG-ACRIN Cancer Research Group · unknown · Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT02314169 · Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

  National Cancer Institute (NCI) · active not recruiting · Anal Canal Squamous Cell Carcinoma, Metastatic Anal Canal Carcinoma, Stage IV Anal Cancer AJCC v8 · principal investigator
• Ph2
  NCT01906008 · Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients

  M.D. Anderson Cancer Center · completed · Colorectal Cancer · principal investigator
• Ph2
  NCT00397878 · AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

  National Cancer Institute (NCI) · terminated · Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer · principal investigator
• N/A
  NCT00354705 · Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients

  M.D. Anderson Cancer Center · unknown · Colon Cancer · principal investigator
• Ph2
  NCT00118105 · S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer

  SWOG Cancer Research Network · withdrawn · Colorectal Cancer, Metastatic Cancer · principal investigator
• Ph2
  NCT00093379 · Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer

  M.D. Anderson Cancer Center · completed · Anal Cancer · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-11 17:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
  U10CA180858 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2014 to 2017 · $688,299 awarded in 2017
  Same name and institution; not confirmed by an ID
• U10 Full Member Application Affiliated with SWOG
  U10CA105409 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2012 to 2013 · $341,201 awarded in 2013
  Same name and institution; not confirmed by an ID
• Determinants of Efficacy to the Akt Inhibitor Perifosine in Colorectal Cancer
  R21CA158676 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2011 to 2012 · $103,095 awarded in 2012
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• ECOG-ACRIN Network Group Operations Center
  U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2020 to 2026
  Named on NCT04444921, NCT02560298
• Leadership, Planning and Evaluation
  P30CA016359 · NCI · YALE UNIVERSITY · PI Eric P. Winer · fiscal years 2020 to 2026
  Named on NCT02314169
• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2020 to 2026
  Named on NCT02314169
• UM1CA186704
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT02314169
• The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
  UM1CA186712 · NCI · OHIO STATE UNIVERSITY · PI SUSANNE M ARNOLD, WILLIAM E. CARSON, Narendranath Epperla · fiscal years 2020 to 2026
  Named on NCT02314169
• UM1CA186716
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT02314169
• Experimental Medicine Program
  P30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2020 to 2026
  Named on NCT00397878, NCT00093379
• U10CA032102
  RePORTER returned no project for this number; it is shown as the registry gives it.
  Named on NCT00118105